|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-5-21
|
|
pubmed:abstractText |
Plasma lipoprotein levels are determined by the balance between lipoprotein production and clearance. Recently, angiopoietin-like protein 4 (ANGPTL4) was uncovered as a novel endocrine factor that potently raises plasma triglyceride levels by inhibiting triglyceride clearance. However, very little is known about ANGPTL4 in human. Here we set out to identify physiological determinants of plasma ANGPTL4 levels in humans, focusing on the effect of energy restriction and plasma FFAs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ANGPTL4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/ANGPTL4 protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Albuterol,
http://linkedlifedata.com/resource/pubmed/chemical/Angiopoietins,
http://linkedlifedata.com/resource/pubmed/chemical/Angptl4 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Fat Emulsions, Intravenous,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Nonesterified,
http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1524-4636
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
969-74
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19342599-Adrenergic beta-Agonists,
pubmed-meshheading:19342599-Adult,
pubmed-meshheading:19342599-Albuterol,
pubmed-meshheading:19342599-Angiopoietins,
pubmed-meshheading:19342599-Animals,
pubmed-meshheading:19342599-Caloric Restriction,
pubmed-meshheading:19342599-Cells, Cultured,
pubmed-meshheading:19342599-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19342599-Exercise,
pubmed-meshheading:19342599-Fat Emulsions, Intravenous,
pubmed-meshheading:19342599-Fatty Acids, Nonesterified,
pubmed-meshheading:19342599-Humans,
pubmed-meshheading:19342599-Hypolipidemic Agents,
pubmed-meshheading:19342599-Intestines,
pubmed-meshheading:19342599-Liver Neoplasms,
pubmed-meshheading:19342599-Male,
pubmed-meshheading:19342599-Mice,
pubmed-meshheading:19342599-Middle Aged,
pubmed-meshheading:19342599-Myocytes, Cardiac,
pubmed-meshheading:19342599-RNA, Messenger,
pubmed-meshheading:19342599-Rats,
pubmed-meshheading:19342599-Time Factors,
pubmed-meshheading:19342599-Transfection,
pubmed-meshheading:19342599-Up-Regulation,
pubmed-meshheading:19342599-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids.
|
|
pubmed:affiliation |
Nutrigenomics Consortium, TI Food and Nutrition, Wageningen, The Netherlands. sander.kersten@wur.nl
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
